Stimulant medication for the treatment of attention-deficit hyperactivity disorder: Evidence-b(i)ased practice?

Psychiatric Bulletin

Volumn 29, Issue 8, 2005, Pages 284-287

  Bailly, Lionel ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; METHYLPHENIDATE; PLACEBO; SALBUTAMOL;

AGGRESSIVENESS; AGITATION; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BEREAVEMENT; CHILD ABUSE; CHILD PARENT RELATION; CLINICAL TRIAL; DRUG MARKETING; EVIDENCE BASED MEDICINE; HEARING IMPAIRMENT; HUMAN; HYPERKINESIA; NERVOUSNESS; SIDE EFFECT; SLEEP DISORDER;

EID: 23844434858     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.29.8.284     Document Type: Article

References (15)

1. BENNETT, K. & HAGGARD, M. (1999) Behaviour and cognitive outcomes from middle ear disease. Archives of Disease in Childhood, 80, 28-35.
2. BENNETT, K., HAGGARD, M., SILVA, P., et al (2001) Behaviour and developmental effects of otitis media with effusion into the teens. Archives of Disease in Childhood, 85, 91-95.
3. BLACKMAN, J. (1999) Attention-deficit/hyperactivity disorder in preschoolers. Does it exist and should we treat it? Pediatric Clinics of North America, 46, 1011-1025.
4. DOWDNEY, L. (2000) Childhood bereavement following parental death. Journal of Child Psychology and Psychiatry, 41, 819-830.
5. GUSHURST, C. (2003) Child abuse: Behavioral aspects and other associated problems. Pediatric Clinics of North America, 50, 919-938.
6. HUTTON, C. & BRADLEY, B. (1994) Effects of sudden infant death on bereaved siblings: a comparative study. Journal of Child Psychology and Psychiatry, 35, 723-732.
7. KIM, E. & MIKLOWITZ, D. (2002) Childhood mania, attention deficit hyperactivity disorder and conduct disorder: a critical review of diagnostic dilemmas. Bipolar Disorders, 4, 215-225.
8. KOSCHACK, J., KUNERT, H., DERICHS, G., et al (2003) Impaired and enhanced attentional function in children with attention deficit/hyperactivity disorder. Psychological Medicine, 33, 481-489.
9. NATIONAL INSTITUTE FOR DRUG ABUSE COMMUNITY EPIDEMIOLOGY WORK GROUP (2000) Epidemiologic Trends in Drug Abuse, Volume 1. Highlights and Executive Summary. June 2000. Bethesda, MD: National Institutes of Health (available at http://www.drugabuse.gov/pdf/cewg/cewg600.pdf).
10. NOVARTIS PHARMACEUTICALS (2004) Ritalin. East Hanover, NJ: Novartis Pharmaceuticals (available at http://www.pharma.us.novartis.com/product/pi/pdf/ritalin_ritalin-sr.pdf).
11. O'BRIEN, L., HOLBROOK, C., MERVIS, C., et al (2003) Sleep and neurobehavioral characteristics of 5- to 7-year-old children with parentally reported symptoms of attention-deficit/hyperactivity disorder. Pediatrics, 111, 554-563.
12. RAPOPORT, J., BUCHSBAUM, M., WEINGARTNER, H., et al (1980) Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men. Archives of General Psychiatry, 37, 933-941.
13. ROYAL COLLEGE OF PSYCHIATRISTS (2004a) Child and abuse and neglect: the emotional effects. In Mental Health and Growing Up (3rd edn) (eds G. Rose & A. York), p. 19. London: Royal College of Psychiatrists (available at http://www.rcpsych.ac.uk/info/mhgu/newmhgu19.htm).
14. ROYAL COLLEGE OF PSYCHIATRISTS (2004b) The restless and excitable child. In Mental Health and Growing Up (3rd edn) (eds G. Rose & A. York), p. 1. London: Royal College of Psychiatrists (available at http://www.rcpsych.ac.uk/info/mhgu/newmhgu1.htm).
15. SHIRE US (2004) Adderall XR. Prescribing Information. Newport, KY: Shire US (available at http://www.adderallxr.com/pdf/prescribing_information.pdf).